CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals. The company executes trade through its electronic trading platforms, open outcry, and privately negotiated transactions, as well as provides hosting, connectivity, and customer support for electronic trading through its co-location services. It also provides clearing and settlement services for exchange-traded contracts, as well as for cleared swaps; and regulatory reporting solutions for market participants through its repository services in the United States, the United Kingdom, Canada, and Australia. In addition, the company offers a range of market data services, including live quotes, delayed quotes, market reports, and historical data services, as well as index services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Security & commodity brokers, dealers, exchanges & services
Sub-IndustrySpecialized Finance
SectorFinance
Current SymbolNASDAQ:CME
Previous Symbol
CUSIP12572Q10
Phone312-930-1000
Debt
Debt-to-Equity Ratio0.15
Current Ratio1.09
Quick Ratio1.09
Price-To-Earnings
Trailing P/E Ratio38.32
Forward P/E Ratio27.45
P/E Growth2.52
Sales & Book Value
Annual Sales$3.64 billion
Price / Sales17.04
Cash Flow$5.2617 per share
Price / Cash Flow34.74
Book Value$66.07 per share
Price / Book2.77
Profitability
EPS (Most Recent Fiscal Year)$4.77
Net Income$4.06 billion
Net Margins113.67%
Return on Equity9.18%
Return on Assets2.95%
Miscellaneous
Employees2,830
Outstanding Shares339,860,000
Market Cap$63.77 billion
OptionableOptionable
CME Group (NASDAQ:CME) Frequently Asked Questions
What is CME Group's stock symbol?
CME Group trades on the NASDAQ under the ticker symbol "CME."
How often does CME Group pay dividends? What is the dividend yield for CME Group?
CME Group announced a dividend on Wednesday, December 5th. Stockholders of record on Friday, December 28th will be given a dividend of $1.75 per share on Wednesday, January 16th. The ex-dividend date is Thursday, December 27th. View CME Group's Dividend History.
How were CME Group's earnings last quarter?
CME Group Inc (NASDAQ:CME) issued its quarterly earnings data on Thursday, October, 25th. The financial services provider reported $1.45 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.42 by $0.03. The financial services provider had revenue of $904.20 million for the quarter, compared to analysts' expectations of $910.50 million. CME Group had a net margin of 113.67% and a return on equity of 9.18%. View CME Group's Earnings History.
When is CME Group's next earnings date?
What price target have analysts set for CME?
15 analysts have issued 12-month target prices for CME Group's shares. Their predictions range from $170.00 to $220.00. On average, they anticipate CME Group's stock price to reach $194.40 in the next year. This suggests a possible upside of 6.4% from the stock's current price. View Analyst Price Targets for CME Group.
What is the consensus analysts' recommendation for CME Group?
15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 6 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CME Group.
Has CME Group been receiving favorable news coverage?
Press coverage about CME stock has been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CME Group earned a news sentiment score of 2.0 on InfoTrie's scale. They also assigned media coverage about the financial services provider a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an effect on the company's share price in the next several days.
Are investors shorting CME Group?
CME Group saw a drop in short interest in the month of November. As of November 30th, there was short interest totalling 3,900,135 shares, a drop of 45.5% from the November 15th total of 7,151,517 shares. Based on an average daily trading volume, of 2,262,061 shares, the short-interest ratio is presently 1.7 days. Approximately 1.1% of the shares of the stock are short sold. View CME Group's Current Options Chain.
Who are some of CME Group's key competitors?
Some companies that are related to CME Group include Intercontinental Exchange (ICE), DEUTSCHE BOERSE/ADR (DBOEY), T. Rowe Price Group (TROW), Nasdaq (NDAQ), LPL Financial (LPLA), BGC Partners (BGCP), INTL Fcstone (INTL), Yintech Investment (YIN), OTC Markets Group (OTCM), National (NHLD), Primus Guaranty (PRSG) and Cboe Global Markets (CBOE).
Who are CME Group's key executives?
CME Group's management team includes the folowing people:
- Mr. Terrence A. Duffy, Chairman & CEO (Age 60)
- Mr. Bryan Thomas Durkin, Pres (Age 57)
- Mr. John W. Pietrowicz M.B.A., CPA, Sr. MD & CFO (Age 53)
- Mr. Kevin Kometer, Sr. MD & Chief Information Officer (Age 53)
- Mr. Sean P. Tully, Sr. MD and Global Head of Financial & OTC Products (Age 54)
Who are CME Group's major shareholders?
CME Group's stock is owned by many different of institutional and retail investors. Top institutional investors include Capital World Investors (8.50%), Vanguard Group Inc (7.45%), BlackRock Inc. (6.60%), Capital International Investors (4.54%), Capital Research Global Investors (3.21%) and Edgewood Management LLC (2.53%). Company insiders that own CME Group stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Hilda Harris Piell, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Kimberly S Taylor, Leo Melamed, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Institutional Ownership Trends for CME Group.
Which institutional investors are selling CME Group stock?
CME stock was sold by a variety of institutional investors in the last quarter, including Capital World Investors, Deutsche Bank AG, AQR Capital Management LLC, Wells Fargo & Company MN, Renaissance Technologies LLC, Mitsubishi UFJ Trust & Banking Corp, Bank of New York Mellon Corp and Gateway Investment Advisers LLC. Company insiders that have sold CME Group company stock in the last year include Bryan T Durkin, Charles P Carey, Derek Sammann, Hilda Harris Piell, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Leo Melamed, Martin J Gepsman, Ronald A Pankau, Sean Tully, Terrence A Duffy and Timothy S Bitsberger. View Insider Buying and Selling for CME Group.
Which institutional investors are buying CME Group stock?
CME stock was acquired by a variety of institutional investors in the last quarter, including Capital Research Global Investors, Capital International Investors, AustralianSuper Pty Ltd, Edgewood Management LLC, BlackRock Inc., Milestone Resources Group Ltd, Rehmann Capital Advisory Group and Janus Henderson Group PLC. View Insider Buying and Selling for CME Group.
How do I buy shares of CME Group?
Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CME Group's stock price today?
One share of CME stock can currently be purchased for approximately $182.79.
How big of a company is CME Group?
CME Group has a market capitalization of $63.77 billion and generates $3.64 billion in revenue each year. The financial services provider earns $4.06 billion in net income (profit) each year or $4.77 on an earnings per share basis. CME Group employs 2,830 workers across the globe.
What is CME Group's official website?
How can I contact CME Group?
CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected]
MarketBeat Community Rating for CME Group (NASDAQ CME)
MarketBeat's community ratings are surveys of what our community members think about CME Group and other stocks. Vote "Outperform" if you believe CME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CME will underperform the S&P 500 over the long term. You may vote once every thirty days.
